Buffalo, NY, United States of America

Kinex Pharmaceuticals, LLC


USPTO Granted Patents = 15

% Expired Patents = 6.7


Forward Citations = 244

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal David G Hangauer, Jr (15 out of 32 patents)

silverMedal Debasis Patra (6 out of 8 patents)

bronzeMedal Jeremy A Cody (6 out of 8 patents)

4.  Jonathon Salsbury (5 out of 7 patents)

5.  Grant Jackson Palmer (5 out of 18 patents)

6.  Paul Kenneth Isbester (5 out of 8 patents)

7.  Jonathan B Gale (3 out of 11 patents)

8.  Daniel Coughlin (3 out of 7 patents)

9.  Michael J Ciesielski (1 out of 7 patents)

10.  Robert Alan Fenstermaker (1 out of 7 patents)

11.  David G Hangauer (23 patents)

12.  Jonathan Gale (0 patent)


15 patents:

Company Overview
Kinex Pharmaceuticals, LLC is a biopharmaceutical company based in Buffalo, NY, specializing in the development of innovative therapies for cancer and other serious diseases. The organization focuses on advancing small molecule drug candidates that target specific pathways involved in disease progression. With a commitment to scientific excellence, Kinex leverages its expertise in medicinal chemistry and pharmacology to create effective treatment options, aiming to improve patient outcomes and contribute to the evolving landscape of oncology therapeutics.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

15 Patents

#23 in Buffalo, NY

#1,219 in New York

#21,052 in US

#39,921 in the World

Buffalo, NY (US)
Buffalo, NY, United States of America
Forward Citations = 244

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kinex Pharmaceuticals, LLC. Retrieved from https://idiyas.com/company/kinex-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…